/Investor DB

Farvatn Venture — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Notelessnoteless.noinNov 2025

Noteless is a healthcare platform designed to help clinical professionals document patient consultations and manage medical records securely.

Digital HealthHealthtechSaaSOslo, NO

William Vossgård(CEO & Co-Founder)inMikkel Dahl Slettebø(CTO & Co-Founder)inDr. Sarankan Sivakanesan(Chief Medical Officer / MD & Co-Founder)

Co-investorsPlanet 9 CapitalRedstone

Scindoscindo.bioin𝕏Sep 2025 · $5.4M

Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing.

AI & Machine LearningBiotechCleantech

Co-investorsClay CapitalPINCPlanet 9 CapitalSOSVSynBioVenAgFunder+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.